Evidence map›Paper›PMID 42919922›Full record

ReviewHeredity2026

A comprehensive evaluation of computational models for identifying methylation variability in DNA methylation arrays.

Siddhant Meshram, Arindam Fadikar, Ganesan Arunkumar, Suvo Chatterjee

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heredity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Siddhant MeshramDepartment of Epidemiology and Biostatistics, Indiana University, Bloomington, IN, USA.
Arindam FadikarDecision and Infrastructure Sciences Division, Argonne National Laboratory, Lemont, IL, USA.
Ganesan ArunkumarDepartment of Cell Biology and Physiology, University of New Mexico, Albuquerque, NM, USA.
Suvo ChatterjeeDepartment of Epidemiology and Biostatistics, Indiana University, Bloomington, IN, USA. suvchat@iu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA methylation (DNAm) is a key epigenetic modification that regulates gene expression and is involved in biological processes such as development, disease progression, and responses to environmental factors. While differential methylation analysis, which focuses on average methylation differences, is widely used in epigenome-wide association studies, variable methylation (VM) analysis is gaining recognition for its ability to uncover dynamic molecular processes underlying various phenotypic outcomes. VM analysis, which focuses on variability in methylation patterns, is particularly valuable for detecting subtle epigenetic changes that may signal early disease stages or complex mechanisms, such as those observed in cancer, where these changes reflect shifts in gene regulation that may not be captured by average methylation levels. Computational tools for VM analysis utilize a variety of approaches, broadly categorized into feature selection-based, joint location-scale test, and variance-based methods, making tool selection challenging. In this study, we conducted a comprehensive evaluation of eight tools that can be used for VM analysis to provide empirical evidence and guidance for researchers in choosing most appropriate tool. Using extensive simulations, we assessed performance of these tools based on various simulation scenarios and evaluations metrics. Our findings indicate that most tools controlled false discovery rate well, except for DiffVar in certain scenarios. All tools had limited power under a small sample size and moderate effect size setup which changed as both sample and effect sizes increased. Across all simulation scenarios and evaluation metrics, JLSsc demonstrated favorable performance as compared to other models in identifying VM in DNAm microarray data.

Identifiers

PMID42919922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.